Objective-Despite the early promising results of 18 F-fluorodeoxyglucose positron emission tomography for assessment of vessel wall inflammation, its accuracy in prospective identification of vulnerable plaques has remained limited. Additionally, previous studies have indicated that 18 F-fluorodeoxyglucose uptake alone may not allow for accurate identification of specific macrophage activation states. We aimed to determine whether combined measurement of glucose and glutamine accumulation-the 2 most important bioenergetic substrates for macrophages-improves the distinction of macrophage inflammatory states and can be utilized to image atherosclerosis. 
D evelopment of noninvasive imaging techniques to quantify the abundance of macrophages in atherosclerotic plaques, and more importantly, their inflammatory phenotype, has been the focus of intense research. 1 Macrophages demonstrate high functional heterogeneity and contribute to both the promotion and resolution of inflammation in atherosclerosis. 2 Analogous to the type-1 and type-2 T-helper lymphocyte paradigm, extremes of the macrophage activation spectrum, have been classified as M1 (classically activated) and M2 (alternatively activated) polarization states. 3 The abundance of proinflammatory M1 macrophages has been associated with atherosclerotic plaque vulnerability, whereas inflammation-resolving M2 macrophages seem to be associated with plaque stability. 3 However, despite a few recently suggested ex vivo approaches, for example, folate receptor-β-targeted nuclear imaging, 4 in vivo identification of macrophage activation states has remained a clinical challenge.
The high glycolytic capacity of macrophages has allowed the utilization of 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography to monitor the macrophage burden of atherosclerotic lesions. 5, 6 Recently, it was shown that enhanced glucose uptake and glycolytic activity are pivotal aspects of macrophage activation in response to selected proinflammatory factors, such as hypoxia 7, 8 and modified low density lipoprotein (LDL), 9, 10 as well as pathogen-derived molecules, for example, lipopolysaccharide. 6, 11 However, enhanced glucose uptake is not a feature characteristic of all proinflammatory macrophages. For example, several proinflammatory stimuli with critical roles in atherosclerosis (interferon-γ, tumor necrosis factor-α [TNF-α], and interleukin-1β) do not increase glucose uptake. 6, 7 Similarly, M2 polarization, despite inducing significant changes in cellular metabolism, does not alter glucose uptake. 6 Therefore, despite their significant functional heterogeneity and pathological roles in atherogenesis, pro-and anti-inflammatory macrophage states may not be distinguishable based on the glucose uptake alone, which would limit the utility of 18 F-FDG as a biomarker to monitor macrophage activation and plaque vulnerability.
Glutamine is the most abundant amino acid in the body and serves as a main source of nitrogen and carbon for cells with long-known roles in wound healing and proliferation of malignant cells. 12 Recent metabolomics studies have identified major changes in glutamine metabolism in macrophages on exposure to M1-or M2-polarizing agents. 11, 13 For example, lipopolysaccharide results in a marked intracellular accumulation of succinate, which is derived from glutamine metabolism and acts as an endogenous danger signal and enhances the production of proinflammatory cytokines.
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On the contrary, glutamine has been shown to be critical for the acquisition of the M2 polarization state and production of key anti-inflammatory cytokines through its role in protein glycosylation. 13 Therefore, we hypothesized that combined imaging of glucose and glutamine accumulation would better characterize the metabolic divergence of macrophages and improve the characterization of macrophage inflammatory states. Using polarized murine macrophages in the current study, we demonstrated that the increased glutamine accumulation in inflammation-resolving macrophages induced by interleukin-4 (MΦ ) and the enhanced 2-deoxyglucose accumulation in the proinflammatory macrophages induced by lipopolysaccharide (MΦ LPS ) allow for their distinction from the proinflammatory macrophages induced by interferon-γ+TNF-α (MΦ IFN-γ+TNF-α ), which show glucose and glutamine uptake that is comparable with unstimulated macrophages (MΦ 0 ). Additionally, we showed in our proof-of-principle ex vivo autoradiography experiments that 18 F-FDG and 14 C-glutamine have distinct accumulation patterns in atherosclerotic plaques of LDL receptor-null (LDL-R −/− ) mice.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Characterization of Polarized Macrophage Phenotypes
The gene expression profiles of macrophages exposed to lipopolysaccharide (MΦ LPS ), M1-polarizing agents (MΦ IFN-
), or an M2-polarizing agent (MΦ IL-4 ) were determined using a panel of polarization markers (Figure 1 ). Both interferon-γ+TNF-α and lipopolysaccharide upregulated the expression of distinct sets of M1 markers, that is, Cxcl9, Cxcl10, Il12b, and Stat1 in MΦ IFN-γ+TNF-α ; and Cxcl10, Il12b, Nos2, Stat1, and Tnf in MΦ LPS ( Figure 1A ). MΦ LPS also showed increased expression of several M2 polarization markers, for example, Arg1, consistent with the development of an endotoxin-tolerant phenotype. 6 The principal component analysis score plots of M1 and M2 markers illustrate the separate clustering of MΦ IFN-γ+TNF-α and MΦ LPS , confirming their distinct proinflammatory states ( Figure 1B  and 1C ). In addition, the M2 polarization state of MΦ was confirmed based on the expression of multiple M2 polarization markers ( Figure 1A ), which showed a clustering distinct from the other activation states in the principal component analysis score plot ( Figure 1C ).
Time Course Analysis of 3 H-2-Deoxyglucose and 3 H-Glutamine Uptakes
We noted a ≈2-fold reduction in 3 H-2-deoxyglucose accumulation during the initial 24 hours after plating of MΦ 0 , which was paralleled by a 2-fold increase in 3 H-glutamine accumulation ( Figure I in the online-only Data Supplement). Therefore, substrate accumulations in polarized macrophages are presented as normalized values to the uptake of MΦ 0 at individual time points to adjust for this platingrelated effect.
MΦ IFN-γ+TNF-α demonstrated only a modest and transient increase in 3 H-2-deoxyglucose accumulation at 24 hours (1.6-fold compared with MΦ 0 ; P<0.05), which returned back to the level of MΦ 0 by 48 hours (Figure 2A ). However, lipopolysaccharide promoted a steady increase in 3 H-2-deoxyglucose accumulation, which at 48 hours reached 6.8-fold of levels in MΦ 0 (P<0.001; Figure 2A ). Unlike the MΦ IFN-γ+TNF-α , which demonstrated levels of 3 H-glutamine accumulation comparable with MΦ 0 throughout the 2-day stimulation ( Figure 2B ), MΦ LPS showed a biphasic response characterized by an early drop at 6 hours to 67% (P<0.01), followed by a steady increase to baseline levels at 24 hours, and a 1.3-fold increase in the accumulation after 48 hours relative to MΦ 0 (P<0.01; Figure 2B ). For the first 6 hours, 3 H-glutamine accumulation in MΦ IL-4 TNF-α tumor necrosis factor-α remained similar to that seen in MΦ 0 but increased to 1.4-fold above the MΦ 0 level after 24 hours and remained constant for the next 24 hours (P<0.001; Figure 2B ). The distinct profiles of the 3 macrophage activation states is best illustrated by plotting their respective levels of 3 H-2-deoxyglucose versus 3 H-glutamine accumulation ( Figure 2C ).
Expression of Glucose and Glutamine Transporters in Polarized Macrophages
We analyzed the mRNA expression of transporters that may account for the different uptake of glucose and glutamine in macrophages under different activation states. mRNA expression of Glut1 (glucose transporter-1), also called Slc2a1 (solute carrier family 2, member 1)-a major glucose transporter in macrophages 6 Glutamine transport is a complex process and mediated through several amino acid transporters, including sodiumdependent neutral amino acid transporters, for example, SLC1A5 and LAT1 (large neutral amino acid transporter).
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Expression of Glucose and Glutamine Transporters by Plaque Macrophages
To assess whether glucose or glutamine transporters were expressed in atherosclerotic plaques in vivo, the expression of GLUT1, SLC1A5, and SLC3A2 was examined by fluorescent immunostaining in aortic root atherosclerotic lesions of LDL-R −/− mice ( Figure 4) . Furthermore, to determine whether the expression of the 3 transporters was present in lesion macrophages, we performed coimmunostaining with an antibody against CD68-a pan monocyte/macrophage marker. All 3 transporters were abundantly expressed in atherosclerotic plaques and were primarily colocalized to CD68 + macrophages (Figure 4) . Unlike the relatively ubiquitous expression of GLUT1 by plaque macrophages, SLC1A5 and SLC3A2 expression was more prominent on the medial and luminal sides of the plaques, respectively (Figure 4 ). In addition, SLC3A2, but not SLC1A5, expression could be detected in the aortic media and adventitia ( Figure 4 , yellow boxes in the right panels).
Ex Vivo Autoradiography of Aorta
To assess the feasibility of a combined metabolic imaging approach, the uptake of both 18 F-FDG and 14 C-glutamine was measured in aortas isolated from LDL-R −/− mice fed with high-fat diet for 3 and 12 months using digital ex vivo autoradiography. Focal areas of increased 18 F-FDG and 14 C-glutamine accumulation were present along the aortas at both time points ( Figure 5A ; Figure III in the online-only Data Supplement). Interestingly, there was a considerable heterogeneity in the accumulation of 18 F-FDG and 14 C-glutamine, with plaques that avidly take up either both or only one of the metabolites. Of note, whereas the majority of atherosclerotic plaques with high 18 F-FDG accumulation in the thoracic and proximal abdominal aorta demonstrated low-to-intermediate 14 C-glutamine accumulation, the lesions in the distal abdominal aorta and proximal common iliac arteries had an intense accumulation of both 18 F-FDG and 14 C-glutamine, reflecting potential differences in plaque biology at different regions of aorta. The presence of unlabeled glutamine markedly decreased the accumulation of 14 C-glutamine by atherosclerotic plaques, indicating the specificity of uptake ( Figure 5B) .
Quantification of the maximal accumulation in various segments of the aorta in 3-month high-fat diet-fed mice demonstrated a 6.6-fold higher normalized uptake of 18 F-FDG compared with 14 C-glutamine, which in the abdominal aorta reaches ≤52.0-fold for 18 F-FDG ( Figure 5C ) and 7.9-fold for 14 C-glutamine ( Figure 5D ) relative to the activity in the buffer. A similar pattern was observed in aortas of 12-month high-fat diet-fed mice, although with an overall trend toward a decreased accumulation of both substrates, in which the the activity present in the uptake buffer, respectively. Consistent with the visual assessment of the autoradiography images, the maximal 14 C-glutamine accumulation in the atherosclerotic lesions from abdominal aorta was significantly higher than the ascending aorta (2.9-and 4.8-fold at 3 and 12 months, respectively), aortic arch (2.3-and 2.0-fold at 3 and 12 months, respectively), and descending thoracic aorta (2.0-and 2.8-fold at 3 and 12 months, respectively; Figure 5D ; Figure IIIC in the online-only Data Supplement). The specificity of 14 C-glutamine accumulation was confirmed by quantification of the autoradiography images of aortas coincubated with unlabeled glutamine, which significantly reduced the maximal plaque accumulation throughout the aorta, reaching ≤4.4-fold in plaques within the abdominal aorta ( Figure 5D ).
Nonatherosclerotic aortas from normal diet-fed wild-type mice demonstrated a significantly lower 14 C-glutamine accumulation throughout the aorta ( Figure IV in the online-only Data Supplement).
Heterogenous Expression of Glucose and Glutamine Transporters Throughout the Aorta
The expression of selected M1 (Cxcl9, Il1b, Il6, Tnfa, and Nos2) and M2 (Arg1, Ccl9, Cd36, Retnla, and Mrc1) polarization markers was evaluated in different segments of atherosclerotic aortas from LDL-R −/− mice fed with high-fat diet for 3 months using principal component analysis. As demonstrated by a principal component analysis score plot ( Figure V in the online-only Data Supplement), different aortic segments clustered separately, indicating their heterogenous expression of macrophage polarization markers. Consistent with the high accumulation of 14 C-glutamine in atherosclerotic plaques of the abdominal aorta, we noted a significantly higher expression of Slc1a5 and Slc3a2 in the abdominal aorta compared with the remaining segments ( Figure 6 ). Despite the fact that 18 F-FDG accumulation was similar in the different aortic segments, the expression of Slc2a1 (ie, Glut1) was also significantly higher in the abdominal aorta compared with the remaining segments.
Discussion
The broad metabolic specificity of 18 F-FDG, which targets an essential and ubiquitous metabolic process, that is, glucose utilization, is a major limitation of 18 F-FDG positron emission tomography in monitoring phenotypic changes of macrophages in inflammatory processes. Recent state-of-the-art metabolomics studies have shown that glutamine metabolism reprogramming is critical for both pro-and anti-inflammatory activation of macrophages. 11, 13 This finding prompted us to determine whether this intracellular metabolic reprogramming is associated with detectable changes in glutamine accumulation, which could be utilized for discrimination of macrophage polarization states.
Our data demonstrate that the combination of 2-deoxyglucose and glutamine accumulation allows for the discrimination of distinct polarization phenotypes in macrophages (Table) . We also demonstrated significant induction of 2 different glutamine transporters, that is, Slc1a5 in MΦ and Slc3a2 in MΦ LPS , as potential mechanisms of enhanced glutamine accumulation in activated macrophages and confirmed the expression of these transporters in plaque macrophages. Additionally, we demonstrated a heterogenous pattern of glutamine accumulation in murine aortic atherosclerotic lesions which is distinct from 2-deoxyglucose uptake. Together, our study identifies glutamine metabolism as a novel metabolic target for noninvasive imaging of macrophage phenotypes in atherosclerosis, which may improve the characterization of the inflammatory state of the vessel wall. Interestingly, the availability and promising experience with 18 F-fluoroglutamine for imaging human neoplasms, for example, glioma, provide a venue to explore the utility of glutamine-targeted imaging in inflammatory processes. 15 Our data demonstrate a significant divergence in glutamine accumulation depending on the macrophage activation state, which may be exploited to overcome the limitations of 18 F-FDG 6,7 for a better characterization of specific macrophage phenotypes in inflammatory processes. The ability to label glutamine with short half-life isotopes, for example, 11 C and 13 N, may allow for sequential same-day imaging of glutamine and glucose metabolism in cancers. 12 However, this approach has never been applied to the imaging of inflammation. Our proof-of-principle autoradiography experiments using the short half-life 18 F-FDG and long halflife 14 C-glutamine demonstrate the ex vivo feasibility of this approach. Of note, despite the lower capacity of atherosclerotic lesions to accumulate 14 C-glutamine compared with 18 F-FDG, the maximal 14 C-glutamine activity in plaque was 6-to-8 folds higher than the radioactivity present in the culture media, suggesting a promising level of tracer accumulation in atherosclerotic plaques to provide a diagnostically adequate target-to-blood ratio. Nevertheless, the comparison between the relative uptake values provides a roadmap for optimization of the in vivo imaging and suggests that a longer acquisition time, a higher dose of glutamine, or tracers with a higher specific activity might be required to overcome the lower relative capacity of plaques to accumulate glutamine compared with 18 F-FDG. The in vivo feasibility of our proposed combined imaging approach needs to be further studied to determine the acquisition parameters and optimal tracer dose using radioisotopes suitable for in vivo positron emission tomography imaging. Our experiments point to a considerable heterogeneity in 2-deoxyglucose and glutamine accumulation in atherosclerotic lesions along the aorta of LDL-R −/− mice. Of note, there was a consistent and distinct pattern of enhanced glutamine accumulation in atherosclerotic plaques in the abdominal aorta compared with plaques in the remaining segments, which was associated with a significantly higher expression of Slc1a5 and Slc3a2. Heterogeneity in various aspects of atherosclerotic plaques, including structural, 16 thermal, [16] [17] [18] pH, 19 and matrix metalloproteinase activity, 20 has been previously reported, and the potential implications of such biological heterogeneity for understanding plaque vulnerability have been proposed. 20 To our knowledge, the current study is the first to demonstrate that plaques in different regions of aorta demonstrate considerable metabolic heterogeneity, in particular with respect to glutamine accumulation, which adds another level of biological complexity to molecular imaging of atherosclerosis.
From extrapolating the ex vivo uptake of substrates, one could speculate that the in vivo ratio of glutamine to 2-deoxyglucose accumulation may serve as a surrogate indicator of the prevailing macrophage phenotype. For example, a relatively higher glutamine uptake compared with 2-deoxyglucose accumulation may represent the predominance of an anti-inflammatory macrophage population. In contrast, plaques with a relatively higher 2-deoxyglucose accumulation, compared with glutamine, may represent lesions with a higher content of proinflammatory macrophages. However, the contribution of other vascular and perivascular cells in the differential accumulation of 2-deoxyglucose and glutamine remains to be determined. For examples, perivascular adipose tissue has been reported as a major determinant of 18 F-FDG uptake in atherosclerotic vessels. 21 In this study, perivascular tissues and adventitial fat were carefully removed from aortas before autoradiography experiments to exclude their contribution to 2-deoxyglucose and glutamine accumulation. However, the role of other major vascular cells (eg, endothelial cells and vascular smooth muscle cells) in the differential accumulation of 2-deoxyglucose and glutamine in various segments of atherosclerotic aortas remains to be determined.
Conclusions
In summary, our study provides the first evidence of feasibility and the potential utility of combined imaging of 2-deoxyglucose and glutamine accumulation for better characterization of the inflammatory state within atherosclerotic plaques. Further biological characterization is required to evaluate the potential benefits of an imaging approach based on the combination of 2-deoxyglucose/glutamine accumulation in the assessment of vessel wall inflammation, in particular in predicting plaque vulnerability.
